BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10825762)

  • 1. Multicenter registry to evaluate the efficacy of the NIROYAL stent in de novo or restenotic coronary stenosis.
    Cremonesi A; Benit E; Carlier M; Colombo A; Piva R; Probst P; Wirtzfeld A; Pico-Bourdonnec C; Corcos T
    J Invasive Cardiol; 2000 May; 12(5):225-32. PubMed ID: 10825762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of stents for small coronary arteries. Results of the Multi-Link 2.5 Portuguese Registry.
    Seabra-Gomes R; Farto eAbreu P; Marques AL; Pereira H; da Cunha JA; Carvalho H; Ribeiro VG; Garcia LM; Mourão L; dos Santos LP; Providência L; Figueiredo L; Almeida M; Cavaco D
    Rev Port Cardiol; 2001 Sep; 20(9):819-37. PubMed ID: 11763595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elective stenting in small coronary arteries: results of the Italian prospective multicenter registry MICROSCOPE.
    Airoldi F; Di Mario C; Presbitero P; Maiello L; Carcagnì A; Bortone A; Cremonesi A; Castriota F; Frasheri A; Rubino A; Pernice V; Rubartelli P; Reimers B; Colombo A
    Ital Heart J; 2002 Jul; 3(7):406-11. PubMed ID: 12189969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct coronary stent implantation: safety, feasibility, and predictors of success of the strategy of direct coronary stent implantation.
    Laarman G; Muthusamy TS; Swart H; Westendorp I; Kiemeneij F; Slagboom T; van der Wieken R
    Catheter Cardiovasc Interv; 2001 Apr; 52(4):443-8. PubMed ID: 11285596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-link Vision and MiniVision stent registry in Asian patients with coronary artery disease: a prospective, multi-center study.
    Xu YW; Wei YD; Tang K; Chen YQ; Li WM; Yu XJ; Qin YW; Qi GX; Qu P; Hou YQ; Jain A; Grant P; Ramesh G; Ramesh B; Piamsomboon C; Kuanprasert S; Gwon HC; Cho YH; Kamar HH; Huang CX
    Chin Med J (Engl); 2007 Jun; 120(12):1093-6. PubMed ID: 17637228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors predictive of cardiac events and restenosis after sirolimus-eluting stent implantation in small coronary arteries.
    Lee CW; Suh J; Lee SW; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2007 May; 69(6):821-5. PubMed ID: 17191211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are drug-eluting stents indicated in large coronary arteries? Insights from a multi-centre percutaneous coronary intervention registry.
    Yan BP; Ajani AE; New G; Duffy SJ; Farouque O; Shaw J; Sebastian M; Lew R; Brennan A; Andrianopoulos N; Reid C; Clark DJ;
    Int J Cardiol; 2008 Nov; 130(3):374-9. PubMed ID: 18706719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients: the EVASTENT Matched-Cohort Registry.
    Machecourt J; Danchin N; Lablanche JM; Fauvel JM; Bonnet JL; Marliere S; Foote A; Quesada JL; Eltchaninoff H; Vanzetto G;
    J Am Coll Cardiol; 2007 Aug; 50(6):501-8. PubMed ID: 17678732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Frontier stent registry: safety and feasibility of a novel dedicated stent for the treatment of bifurcation coronary artery lesions.
    Lefèvre T; Ormiston J; Guagliumi G; Schultheiss HP; Quilliet L; Reimers B; Brunel P; Wijns W; Buettner HJ; Hartmann F; Veldhof S; Miquel K; Su X; van der Giessen WJ
    J Am Coll Cardiol; 2005 Aug; 46(4):592-8. PubMed ID: 16098421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and long-term results of bifurcation stenting (from the Coroflex Registry).
    Rux S; Sonntag S; Schulze R; Rau M; Weber F; Mühling H; Cioppa A; Kleber FX;
    Am J Cardiol; 2006 Nov; 98(9):1214-7. PubMed ID: 17056331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
    Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
    Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stenting small coronary arteries: The Multi-Link PIXEL Multicenter Italian Registry.
    Casella G; Prati F;
    J Invasive Cardiol; 2003 Jul; 15(7):371-6. PubMed ID: 12840232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The new Polish stent Chopin. Assessment of safety and efficacy in the treatment of de-novo coronary lesions using percutaneous angioplasty.
    Buszman P; Zurakowski A; Kinasz L; Gorycki B; Król M; Lewicki A; Flak Z; Milewski K; Zurek P
    Kardiol Pol; 2005 May; 62(5):451-9; discussion 460-1. PubMed ID: 15928722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of true bifurcation stenosis by elective stent implantation in parent vessel and non-stent dilatation of side branch: immediate and follow-up results.
    Gambhir DS; Singh S; Sinha SC; Nair GM; Arora R
    Indian Heart J; 2000; 52(3):289-96. PubMed ID: 10976149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term evaluation of paclitaxel-coated stents for treatment of native coronary lesions. First results of both the clinical and angiographic 18 month follow-up of TAXUS I.
    Büllesfeld L; Gerckens U; Müller R; Grube E
    Z Kardiol; 2003 Oct; 92(10):825-32. PubMed ID: 14579046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions.
    Fan L; Chen LL; Lin CG; Peng YF; Zheng XC; Luo YK; Zhang FL; Chen JH; Yan XP; Huang ZR
    Chin Med J (Engl); 2008 Aug; 121(16):1518-23. PubMed ID: 18982862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-hospital complications and long-term outcomes of the paclitaxel drug-eluting stent in acute ST-elevation myocardial infarction: a real-world experience from a high-volume medical center.
    Shammas NW; Shammas GA; Hahn A; Jerin M; Dippel EJ; Winter M
    Cardiovasc Revasc Med; 2009; 10(3):151-5. PubMed ID: 19595395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of stenting for unprotected left main coronary artery disease in 297 patients.
    Han YL; Wang SL; Jin QM; Liu HW; Ma YY; Wang ZL; Wang DM; Luan B; Wang G
    Chin Med J (Engl); 2006 Apr; 119(7):544-50. PubMed ID: 16620694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous revascularization in patients with previous coronary artery bypass graft surgery. Immediate and 1-year clinical outcomes.
    Tejada JG; Velazquez M; Hernandez F; Albarran A; Gomez I; Rodriguez S; Andreu J; Tascon J
    Int J Cardiol; 2009 May; 134(2):201-6. PubMed ID: 18508141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-year clinical outcomes with drug-eluting stents for diabetic patients with de novo coronary lesions: results from a real-world multicenter registry.
    Ortolani P; Balducelli M; Marzaroli P; Piovaccari G; Menozzi A; Guiducci V; Sangiorgio P; Tarantino F; Geraci G; Castriota F; Tondi S; Saia F; Cooke RM; Guastaroba P; Grilli R; Marzocchi A; Maresta A
    Circulation; 2008 Feb; 117(7):923-30. PubMed ID: 18250265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.